Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Serinc5 | Rat | (-)-demecolcine | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of SERINC5 mRNA | CTD | PMID:23649840 | Serinc5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SERINC5 mRNA | CTD | PMID:22206623 | Serinc5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SERINC5 mRNA | CTD | PMID:22298810 | Serinc5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SERINC5 mRNA | CTD | PMID:28213091 | Serinc5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Serinc5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SERINC5 mRNA | CTD | PMID:21570461 | Serinc5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SERINC5 mRNA | CTD | PMID:21215274 and PMID:33387578 | Serinc5 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of SERINC5 mRNA | CTD | PMID:21346803 | Serinc5 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SERINC5 mRNA | CTD | PMID:30851411 | Serinc5 | Rat | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of SERINC5 mRNA | CTD | PMID:19162173 | Serinc5 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SERINC5 mRNA | CTD | PMID:28973697 | Serinc5 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SERINC5 mRNA | CTD | PMID:24780913 | Serinc5 | Rat | aflatoxin B1 | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SERINC5 mRNA | CTD | PMID:27153756 | Serinc5 | Rat | aflatoxin B1 | increases methylation | ISO | SERINC5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SERINC5 intron | CTD | PMID:30157460 | Serinc5 | Rat | Aflatoxin B2 alpha | affects methylation | ISO | SERINC5 (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of SERINC5 intron | CTD | PMID:30157460 | Serinc5 | Rat | all-trans-retinoic acid | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SERINC5 mRNA | CTD | PMID:15498508 and PMID:33167477 | Serinc5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SERINC5 mRNA | CTD | PMID:16483693 | Serinc5 | Rat | benzo[a]pyrene | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SERINC5 mRNA | CTD | PMID:19770486 | Serinc5 | Rat | benzo[a]pyrene | affects methylation | ISO | SERINC5 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SERINC5 intron | CTD | PMID:30157460 | Serinc5 | Rat | benzo[a]pyrene | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SERINC5 mRNA | CTD | PMID:22228805 | Serinc5 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SERINC5 mRNA | CTD | PMID:25181051 | Serinc5 | Rat | bisphenol A | affects methylation | ISO | SERINC5 (Homo sapiens) | 6480464 | bisphenol A affects the methylation of SERINC5 gene | CTD | PMID:31601247 | Serinc5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SERINC5 mRNA | CTD | PMID:30816183 | Serinc5 | Rat | bisphenol A | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SERINC5 mRNA | CTD | PMID:27685785 and PMID:29275510 | Serinc5 | Rat | bisphenol F | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of SERINC5 mRNA | CTD | PMID:38685157 | Serinc5 | Rat | caffeine | decreases phosphorylation | ISO | SERINC5 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of SERINC5 protein | CTD | PMID:35688186 | Serinc5 | Rat | carbon nanotube | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of SERINC5 mRNA | CTD | PMID:25554681 | Serinc5 | Rat | chlorpyrifos | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SERINC5 mRNA | CTD | PMID:37019170 | Serinc5 | Rat | cisplatin | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SERINC5 mRNA | CTD | PMID:27594783 | Serinc5 | Rat | cisplatin | multiple interactions | ISO | SERINC5 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SERINC5 mRNA | CTD | PMID:27392435 | Serinc5 | Rat | cisplatin | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SERINC5 mRNA | CTD | PMID:27392435 | Serinc5 | Rat | clobetasol | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Clobetasol results in increased expression of SERINC5 mRNA | CTD | PMID:27462272 | Serinc5 | Rat | coumestrol | multiple interactions | ISO | SERINC5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA | CTD | PMID:19167446 | Serinc5 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of SERINC5 mRNA | CTD | PMID:27523638 | Serinc5 | Rat | cyclosporin A | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SERINC5 mRNA | CTD | PMID:25562108 | Serinc5 | Rat | Dibutyl phosphate | affects expression | ISO | SERINC5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of SERINC5 mRNA | CTD | PMID:37042841 | Serinc5 | Rat | dibutyl phthalate | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of SERINC5 mRNA | CTD | PMID:21266533 | Serinc5 | Rat | diethylstilbestrol | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of SERINC5 mRNA | CTD | PMID:36621641 | Serinc5 | Rat | dioxygen | multiple interactions | ISO | Serinc5 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERINC5 mRNA | CTD | PMID:30529165 | Serinc5 | Rat | dorsomorphin | multiple interactions | ISO | SERINC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Serinc5 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of SERINC5 mRNA | CTD | PMID:29391264 | Serinc5 | Rat | Enterolactone | multiple interactions | ISO | SERINC5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA | CTD | PMID:19167446 | Serinc5 | Rat | epoxiconazole | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SERINC5 mRNA | CTD | PMID:35436446 | Serinc5 | Rat | ethyl methanesulfonate | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of SERINC5 mRNA | CTD | PMID:23649840 | Serinc5 | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of SERINC5 mRNA | CTD | PMID:18035473 | Serinc5 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of SERINC5 mRNA | CTD | PMID:24136188 | Serinc5 | Rat | formaldehyde | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SERINC5 mRNA | CTD | PMID:23649840 | Serinc5 | Rat | fulvestrant | increases methylation | ISO | SERINC5 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of SERINC5 gene | CTD | PMID:31601247 | Serinc5 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SERINC5 mRNA | CTD | PMID:33387578 | Serinc5 | Rat | lead(0) | affects expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Lead affects the expression of SERINC5 mRNA | CTD | PMID:28903495 | Serinc5 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of SERINC5 mRNA | CTD | PMID:30467583 | Serinc5 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of SERINC5 gene | CTD | PMID:35440735 | Serinc5 | Rat | methyl methanesulfonate | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SERINC5 mRNA | CTD | PMID:23649840 | Serinc5 | Rat | methylmercury chloride | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SERINC5 mRNA | CTD | PMID:23179753 | Serinc5 | Rat | mifepristone | decreases expression | EXP | | 6480464 | Mifepristone results in decreased expression of SERINC5 mRNA | CTD | PMID:25972201 | Serinc5 | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of SERINC5 mRNA | CTD | PMID:25729387 | Serinc5 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SERINC5 mRNA | CTD | PMID:25729387 | Serinc5 | Rat | paracetamol | affects expression | ISO | Serinc5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SERINC5 mRNA | CTD | PMID:17562736 | Serinc5 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SERINC5 mRNA | CTD | PMID:33387578 | Serinc5 | Rat | phenobarbital | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of SERINC5 mRNA | CTD | PMID:19270015 | Serinc5 | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of SERINC5 mRNA | CTD | PMID:19162173 | Serinc5 | Rat | rac-lactic acid | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SERINC5 mRNA | CTD | PMID:30851411 | Serinc5 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SERINC5 mRNA | CTD | PMID:28374803 | Serinc5 | Rat | SB 431542 | multiple interactions | ISO | SERINC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Serinc5 | Rat | silicon dioxide | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of SERINC5 mRNA | CTD | PMID:25895662 | Serinc5 | Rat | silver atom | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Silver results in decreased expression of SERINC5 mRNA | CTD | PMID:27131904 | Serinc5 | Rat | silver(0) | decreases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Silver results in decreased expression of SERINC5 mRNA | CTD | PMID:27131904 | Serinc5 | Rat | sodium arsenite | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SERINC5 mRNA | CTD | PMID:36209798 | Serinc5 | Rat | sulforaphane | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of SERINC5 mRNA | CTD | PMID:26833863 | Serinc5 | Rat | tamibarotene | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | tamibarotene results in decreased expression of SERINC5 mRNA | CTD | PMID:15498508 | Serinc5 | Rat | tetrachloromethane | affects expression | ISO | Serinc5 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of SERINC5 mRNA | CTD | PMID:17484886 and PMID:31919559 | Serinc5 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SERINC5 mRNA | CTD | PMID:30723492 | Serinc5 | Rat | tetrachloromethane | increases expression | ISO | Serinc5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SERINC5 mRNA | CTD | PMID:27339419 | Serinc5 | Rat | thiram | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Thiram results in increased expression of SERINC5 mRNA | CTD | PMID:38568856 | Serinc5 | Rat | titanium dioxide | increases methylation | ISO | Serinc5 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of SERINC5 promoter | CTD | PMID:35295148 | Serinc5 | Rat | titanium dioxide | decreases methylation | ISO | Serinc5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SERINC5 gene | CTD | PMID:35295148 | Serinc5 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SERINC5 mRNA | CTD | PMID:25729387 | Serinc5 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of SERINC5 mRNA | CTD | PMID:25729387 | Serinc5 | Rat | trichostatin A | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of SERINC5 mRNA | CTD | PMID:26272509 | Serinc5 | Rat | trichostatin A | multiple interactions | ISO | SERINC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERINC5 mRNA | CTD | PMID:27188386 | Serinc5 | Rat | triclosan | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of SERINC5 mRNA | CTD | PMID:30510588 | Serinc5 | Rat | triphenyl phosphate | affects expression | ISO | SERINC5 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SERINC5 mRNA | CTD | PMID:37042841 | Serinc5 | Rat | urethane | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Urethane results in increased expression of SERINC5 mRNA | CTD | PMID:28818685 | Serinc5 | Rat | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SERINC5 mRNA | CTD | PMID:23665938 | Serinc5 | Rat | valproic acid | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SERINC5 mRNA | CTD | PMID:23179753 | Serinc5 | Rat | valproic acid | affects expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SERINC5 mRNA | CTD | PMID:25979313 | Serinc5 | Rat | valproic acid | decreases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SERINC5 mRNA | CTD | PMID:23179753 and PMID:26272509 | Serinc5 | Rat | valproic acid | multiple interactions | ISO | SERINC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERINC5 mRNA | CTD | PMID:27188386 | Serinc5 | Rat | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of SERINC5 gene | CTD | PMID:31682807 | Serinc5 | Rat | vincristine | increases expression | ISO | SERINC5 (Homo sapiens) | 6480464 | Vincristine results in increased expression of SERINC5 mRNA | CTD | PMID:23649840 | |